- Tytuł:
- Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.
- Autorzy:
- Źródło:
- Blood pressure [Blood Press] 2022 Dec; Vol. 31 (1), pp. 210-224.
- Typ publikacji:
- Journal Article; Review
- MeSH Terms:
-
Cardiovascular Diseases*
Heart Failure*
Hypertension*
Adrenergic beta-Antagonists ; Antihypertensive Agents ; Atenolol ; Comorbidity ; Humans ; Metoprolol ;Oxprenolol ; Propranolol
Czasopismo naukowe